A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...
2don MSN
Lifelong drugs for autoimmune diseases don't work well. Now scientists are trying something new
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...
Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it before it's been fully tested.
The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
Millions in India face chronic kidney disease, with drug-induced damage a significant concern. Common medications like NSAIDs, antibiotics, and contrast agents can harm kidneys, especially with ...
Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.
Weight-loss drugs are booming (1) and you’ve probably heard of them: Wegovy, Ozempic, Mounjaro, Zepbound. These GLP-1 medications are helping Americans slim down and manage diabetes — and in some ...
The pharmaceutical industry has its problems, but the multi-billion-dollar supplement industry does too. At least pharmaceuticals have to prove effectiveness and pass rigorous safety and quality tests ...
Florida’s attorney general has filed a lawsuit against Planned Parenthood, claiming the organization is “misrepresenting the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results